It has been demonstrated that the administration of recombinant adiponectin in its complete or isolated form, exerts hypoglycemic effects, decreasing insulin resistance in murine models for obesity and diabetes [128]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.